Trial Profile
Efficacy and safety of Bevacizumab containing chemotherapy in patients with small bowel cancer: a retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Aug 2017 New trial record
- 01 Aug 2017 Results published in the Cancer Chemotherapy and Pharmacology